7-(2-fluorophenyl)-3-(furan-2-yl)-2-((2-methyl-2H-1,2,4-triazol-3-yl)methoxy)pyrazolo[1,5-d][1,2,4]triazine

ID: ALA380110

PubChem CID: 18406909

Max Phase: Preclinical

Molecular Formula: C19H14FN7O2

Molecular Weight: 391.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncnc1COc1nn2c(-c3ccccc3F)nncc2c1-c1ccco1

Standard InChI:  InChI=1S/C19H14FN7O2/c1-26-16(21-11-23-26)10-29-19-17(15-7-4-8-28-15)14-9-22-24-18(27(14)25-19)12-5-2-3-6-13(12)20/h2-9,11H,10H2,1H3

Standard InChI Key:  KWBJTSIHFVATSO-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   18.3578   -8.5036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5414   -8.6476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4243   -9.4642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1648   -9.8280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7394   -9.2361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5557   -9.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0643   -4.2302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4953   -5.0573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4922   -4.2262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7740   -3.8174    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7760   -5.4706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0617   -5.0546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4452   -5.6056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7784   -6.3619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6009   -6.2785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3633   -7.0748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2101   -5.4691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2087   -6.2938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9227   -6.7057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6377   -6.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6343   -5.4631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9198   -5.0552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9160   -4.2302    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.7731   -7.7908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6555   -5.3666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3818   -4.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5570   -4.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3180   -5.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9951   -5.8689    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  2  3  1  0
 14 16  1  0
 11  8  1  0
  8 17  1  0
  3  4  2  0
 17 18  2  0
  8  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
 10  7  2  0
 21 22  2  0
 22 17  1  0
 11 12  1  0
 22 23  1  0
  5  1  1  0
 16 24  1  0
 24  1  1  0
 13 25  1  0
 25 26  2  0
  5  6  1  0
  1  2  2  0
  7 12  1  0
 12 13  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 25  1  0
M  END

Associated Targets(Human)

GABRG2 Tclin GABA-A receptor; alpha-3/beta-3/gamma-2 (1250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA-A receptor; alpha-1/beta-3/gamma-2 (1565 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.37Molecular Weight (Monoisotopic): 391.1193AlogP: 2.90#Rotatable Bonds: 5
Polar Surface Area: 96.16Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.08CX LogP: 2.18CX LogD: 2.18
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: -1.91

References

1. Carling RW, Russell MG, Moore KW, Mitchinson A, Guiblin A, Smith A, Wafford KA, Marshall G, Atack JR, Street LJ..  (2006)  2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.,  16  (13): [PMID:16621541] [10.1016/j.bmcl.2006.03.081]

Source